Evidence map›Paper›PMID 30938050›Full record

ArticleInternational wound journal2019

Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.

Claudio Marasca, Giuseppina Fontanella, Maria C Annunziata, Dario Marasca, Gabriella Fabbrocini

Open access · bronzeAbstract readCase ReportsLetter
In one paragraph

Article in International wound journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Pyoderma Gangrenosum with Biological Agents Therapy: A Systematic Review.Clinical, cosmetic and investigational dermatology · 2025
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Claudio MarascaDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.ORCID https://orcid.org/0000-0002-8401-5730
Giuseppina FontanellaDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.
Maria C AnnunziataDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.
Dario MarascaDepartment of General and Specialistic Surgery, A.O.U. Cardarelli, Naples, Italy.
Gabriella FabbrociniDepartment of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.
University of Naples Federico II · ITOspedale Antonio Cardarelli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdalimumabAnti-Inflammatory AgentsAntineoplastic Combined Chemotherapy ProtocolsHumansImmunosuppressive AgentsMaleMiddle AgedPyoderma GangrenosumTacrolimusTreatment OutcomeAdalimumabAnti-Inflammatory AgentsImmunosuppressive AgentsTacrolimus

Identifiers

PMID30938050
PMCPMC7949406
OpenAlexW2931076272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.